These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2562060)

  • 21. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists.
    Fuller RW; Snoddy HD
    Endocrinology; 1981 Oct; 109(4):1026-32. PubMed ID: 6116593
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
    Klint T; Dahlgren IL; Larsson K
    Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans.
    Mueller EA; Murphy DL; Sunderland T
    Psychopharmacology (Berl); 1986; 89(3):388-91. PubMed ID: 3014595
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel regulation of 5-HT1C receptors: down-regulation induced both by 5-HT1C/2 receptor agonists and antagonists.
    Pranzatelli MR; Murthy JN; Tailor PT
    Eur J Pharmacol; 1993 Jan; 244(1):1-5. PubMed ID: 8420788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of 5-HT1A receptor subtype in the paraventricular nuclei of the hypothalamus induces CRH and ACTH release in the rat.
    Pan L; Gilbert F
    Neuroendocrinology; 1992 Dec; 56(6):797-802. PubMed ID: 1369587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI).
    Li Q; Brownfield MS; Battaglia G; Cabrera TM; Levy AD; Rittenhouse PA; van de Kar LD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):836-44. PubMed ID: 8394920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticotropin and cortisol secretion after central 5-hydroxytryptamine-1A (5-HT1A) receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists.
    Lesch KP; Söhnle K; Poten B; Schoellnhammer G; Rupprecht R; Schulte HM
    J Clin Endocrinol Metab; 1990 Mar; 70(3):670-4. PubMed ID: 1968468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different serotonin receptors mediate blood pressure, heart rate, plasma catecholamine and prolactin responses to m-chlorophenylpiperazine in conscious rats.
    Bagdy G; Szemeredi K; Kanyicska B; Murphy DL
    J Pharmacol Exp Ther; 1989 Jul; 250(1):72-8. PubMed ID: 2746512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MK-212 (6-chloro-2[1-piperazinyl]pyrazine) on schedule-controlled behavior and their reversal by 5-HT antagonists in the pigeon.
    Mansbach RS; Barrett JE
    Neuropharmacology; 1986 Jan; 25(1):13-9. PubMed ID: 2936975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men.
    Meltzer HY; Maes M
    Biol Psychiatry; 1995 Sep; 38(5):310-8. PubMed ID: 7495925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT1B receptors mediate potent contractile responses to 5-HT in rat caudal artery.
    Craig DA; Martin GR
    Br J Pharmacol; 1993 Jul; 109(3):609-11. PubMed ID: 8358560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of 5-hydroxytryptamine receptors in rat stomach fundus.
    Clineschmidt BV; Reiss DR; Pettibone DJ; Robinson JL
    J Pharmacol Exp Ther; 1985 Dec; 235(3):696-708. PubMed ID: 2934542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of metergoline and other serotonin receptor antagonists on serum corticosterone in rats.
    Fuller RW; Snoddy HD
    Endocrinology; 1979 Oct; 105(4):923-8. PubMed ID: 477605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal 5,7-DHT lesions upregulate [3H]mesulergine-labelled spinal 5-HT1C binding sites in the rat.
    Pranzatelli MR
    Brain Res Bull; 1990 Jul; 25(1):151-3. PubMed ID: 2207701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.